Trial intelligence / Profile preview

Retrospective hospitalization study in schizophrenia before oral antipsychotics and after switch to long-acting injectable atypical antipsychotics

RBR-2x86dcRecruiting

Sponsor
Federal University of São Paulo
Start
Aug 2015
Countries
1
01

Overview

Open-label trial in schizophrenia (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Hospitalization rate associated with psychotic relapses. Started Aug 2015; status: recruiting.

02

Conditions

schizophrenia

Beyond the preview

Go deeper on RBR-2x86dc.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-2x86dc.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call